Let-7f-5p Has Antifibrotic Properties and Is Reduced in Circulatory Small Extracellular Vesicles in Progressive Idiopathic Pulmonary Fibrosis
- 1 December 2025
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 211 (12) , 2410-2413
Abstract
No abstract availableKeywords
Funding Information
- Boehringer Ingelheim
- Roche Products
- Lung Foundation Australia
- National Health and Medical Research Council (APP1066128)
- National Health and Medical Research Council (APP114776)
- National Health and Medical Research Council (APP2022914)
- National Health and Medical Research Council (GNT1116371)
- National Health and Medical Research Council (GNT2015613)
- Boehringer Ingelheim
- Roche Products
- Lung Foundation Australia
- National Health and Medical Research Council (APP1066128)
- National Health and Medical Research Council (APP114776)
- National Health and Medical Research Council (APP2022914)
- National Health and Medical Research Council (GNT1116371)
- National Health and Medical Research Council (GNT2015613)
This publication has 10 references indexed in Scilit:
- SOCS domain targets ECM assembly in lung fibroblasts and experimental lung fibrosisScientific Reports, 2024
- Let‑7f‑5p Regulated by Hsa_circ_0000437 Ameliorates Bleomycin‐Induced Skin FibrosisJournal of Cellular Biochemistry, 2024
- A lung targeted miR-29 mimic as a therapy for pulmonary fibrosisEBioMedicine, 2022
- A comparison of the efficiency of RNA extraction from extracellular vesicles using the Qiagen RNeasy MinElute versus Enzymax LLC RNA Tini Spin columns and qPCR of miRNABiology Methods and Protocols, 2021
- A MicroRNA-29 Mimic (Remlarsen) Represses Extracellular Matrix Expression and Fibroplasia in the SkinJournal of Investigative Dermatology, 2019
- A standardised protocol for the evaluation of small extracellular vesicles in plasma by imaging flow cytometryJournal of Immunological Methods, 2019
- Let-7f-5p regulates TGFBR1 in glucocorticoid-inhibited osteoblast differentiation and ameliorates glucocorticoid-induced bone lossInternational Journal of Biological Sciences, 2019
- Let-7 microRNA as a potential therapeutic target with implications for immunotherapyExpert Opinion on Therapeutic Targets, 2018
- MicroRNAs in idiopathic pulmonary fibrosis: involvement in pathogenesis and potential use in diagnosis and therapeuticsActa Pharmaceutica Sinica B, 2016
- Inhibition and Role of let-7d in Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2010